Showing results (61-70 of 143) with videos related to
Sort By:
Pageof 15
Mutation Research|November 1, 1991
Considerations in the U.S. Environmental Protection Agency's testing approach for mutagenicityK L Dearfield, A E Auletta, M C Cimino, et al.Carcinogenesis|July 1, 1994
Deletion mutations in the hprt gene of T-lymphocytes as a biomarker for genomic rearrangements important in human cancersJ C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.Mutation Research|March 1, 1987
Mutagenicity and clastogenicity of teniposide (VM-26) in L5178Y/TK +/- -3.7.2C mouse lymphoma cellsD M DeMarini, K H Brock, C L Doerr, et al.Mutation Research|December 1, 1992
Large deletions are tolerated at the hprt locus of in vivo derived human T-lymphocytesJ C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.Clinical Orthopaedics and Related Research|June 1, 1989
Vascularized autografts for reconstruction of skeletal defects following lower extremity trauma. A reviewF R Nusbickel, P C Dell, M P McAndrew, et al.Mutagenesis|September 1, 1989
Differential mutant quantitation at the mouse lymphoma tk and CHO hgprt lociM M Moore, K Harrington-Brock, C L Doerr, et al.Environmental and Molecular Mutagenesis|January 1, 1994
Multiplex PCR analysis of in vivo-arising deletion mutations in the hprt gene of human T-lymphocytesJ C Fuscoe, L J Zimmerman, K Harrington-Brock, et al.Carcinogenesis|May 1, 1996
Quantification of t(14;18) in the lymphocytes of healthy adult humans as a possible biomarker for environmental exposures to carcinogensJ C Fuscoe, R W Setzer, D D Collard, et al.Environmental Mutagenesis|January 1, 1987
Mutagenesis of L5178Y/TK(+/-)-3.7.2C mouse lymphoma cells by the clastogen ellipticineM M Moore, K H Brock, C L Doerr, et al.Environmental Mutagenesis|January 1, 1987
Mutagenicity and clastogenicity of acrylamide in L5178Y mouse lymphoma cellsM M Moore, A Amtower, C Doerr, et al.Pageof 15